Human clinical trials in Brazil for a potential coronavirus vaccine started this weekend

News24xx.com - Human clinical trials in Brazil for a potential coronavirus vaccine developed by Oxford University.

The trials started this weekend and sponsor by Lemann Foundation.

Trials will count on 2,000 health workers volunteers in Sao Paulo and 1,000 people in Rio de Janeiro and are being conducted by Universidade Federal de Sao Paulo and hospital chain Rede D'Or, respectively.

Read more: Mark Zuckerberg has joined the world's most exclusive club of the ultra-rich.

Brazil's health regulator Anvisa approved human clinical trials for this potential vaccine, developed by Oxford and supported by AstraZeneca Plc, earlier in June. 

Brazil, where the disease is still rife, is the first country outside the United Kingdom to start testing the Oxford vaccine.

Researchers expect to launch the vaccine by year-end.